Cabral Film Tablet

Description

Ingredients and Packaging

Cabral comes impeccably packaged in a cardboard box, housing a blister pack containing 24 film tablets. Included are clear and concise instructions for proper usage, ensuring the patient’s understanding and safety. This product is expertly manufactured and licensed by Recordati İlaç San. ve Tic. A.Ş. in Turkey, a testament to its quality and reliability.

Bioequivalence and Clinical Study

A pivotal clinical study conducted in Turkey meticulously evaluated the bioequivalence of Feniramidol HCl 400 mg Film Tablet (the Test Drug) concerning Cabral 400 mg Film Tablet (the Reference Drug). This study involved healthy male subjects under fed conditions, providing valuable insights into the product’s efficacy and safety profile.

Safety Disclaimer

It is essential to emphasize that the information shared here does not serve as a substitute for the wisdom and judgment of healthcare professionals. This content should not be interpreted as an endorsement of Cabral or any medication’s universal safety, suitability, or effectiveness for every individual.

Therefore, it is of paramount importance to engage in a dialogue with your healthcare provider before initiating any medication.

Cabral Side Effects

As with any medicinal product, Cabral may exhibit side effects in some individuals. These reported side effects encompass:

• Allergic Reactions: Characterized by manifestations such as hives, breathing difficulties, and swelling of the face, lips, tongue, or throat.
• Gastrointestinal Symptoms: Including sensations of stomach fullness and nausea.
• General Symptoms: Such as fatigue and lethargy.
• Sensory Symptoms: Notably, the presence of a burning sensation on the tongue and itching.

Should you experience any of these side effects while taking Cabral, it is imperative to promptly consult your healthcare provider. Their expertise will guide you on managing these side effects and determining whether the continuation of it is advisable.

Medication Interactions

Cabral, a film tablet containing 400 mg of Feniramidol HCl, may interact with other medications. Notably, a known interaction exists with phenytoin, a medication primarily used in the treatment of seizures.F

enyramidol, the active ingredient in it, has the potential to inhibit the metabolism of phenytoin, leading to possible increases in plasma phenytoin levels. Therefore, it is paramount to engage in a comprehensive discussion with your healthcare provider regarding the concurrent use with other medications.

Pregnancy and Breastfeeding

For expectant mothers, Cabral usage during pregnancy is not recommended except in cases where the attending healthcare provider deems it absolutely necessary. If pregnancy occurs during the course of its treatment, swift consultation with your healthcare provider or pharmacist is advised.

Regarding breastfeeding, the transfer of the active ingredient in Cabral, Feniramidol HCl, into breast milk remains uncertain. As such, prior consultation with your healthcare provider or pharmacist is essential before considering it use while breastfeeding.

Duration and Dosage

The duration of Cabral treatment is highly individualized, contingent upon the patient’s specific condition and healthcare provider’s guidance. It is imperative to strictly adhere to your doctor’s instructions and continue its treatment for the prescribed duration. Abruptly discontinuing it without prior consultation with your healthcare provider may exacerbate your condition.

The recommended dosage of Cabral, in the form of a film tablet containing 400 mg of Feniramidol HCl, varies based on individual patient profiles and the nature of the condition being treated. Precise adherence to the instructions provided by your healthcare provider or pharmacist is of paramount importance. Avoid exceeding the recommended dosage or extending the duration of Cabral use without the explicit consent of your healthcare provider.

Conclusion

In closing, Cabral represents a critical tool in the management of sudden, painful muscle contractions associated with the musculoskeletal system. This comprehensive guide aims to provide invaluable insights for both healthcare providers and patients, offering a deeper understanding of its therapeutic potential, potential side effects, and safety considerations.

As you embark on your journey toward musculoskeletal relief, remember the significance of open communication with your healthcare provider, ensuring your treatment aligns with your unique needs and circumstances.